✦ LIBER ✦

Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6

✍ Scribed by Toshiyuki Aramaki; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Shin-ya Kawashiri; Mami Tamai; Kazuhiko Arima; Makoto Kamachi; Satoshi Yamasaki; Hideki Nakamura; Munetoshi Nakashima; Akinari Mizokami; Masako Furuyama; Naoki Matsuoka; Yukitaka Ueki; Hiroaki Ida; Tomoki Origuchi; Kiyoshi Aoyagi; Katsumi Eguchi

Book ID: 106292200
Publisher: Springer
Year: 2009
Tongue: English
Weight: 172 KB
Volume: 19
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-009-0216-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Baseline levels of soluble interleukin-6

Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy

✍ Nishina, N.; Kikuchi, J.; Hashizume, M.; Yoshimoto, K.; Kameda, H.; Takeuchi, T. 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 705 KB

P13 A prospective study of correlation b

P13 A prospective study of correlation between disease activity score (DAS28) and CRP levels in patients with rheumatoid arthritis (RA)

✍ S Ostwal Vikas; J Oak 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

In rheumatoid arthritis patients treated

In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24

✍ Shin-ya Kawashiri; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Ar 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 163 KB

Disease activity score 28 may overestima

Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index

✍ Shin-ya Kawashiri; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Ar 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB

Elevation of serum KL-6 levels in 3 pati

Elevation of serum KL-6 levels in 3 patients with rheumatoid arthritis treated with adalimumab

✍ Masahito Koiwa; Susumu Goto; Kenji Takenouchi; Kenji Takahasi; Toshikazu Kamada; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 280 KB

PMS49 Fatigue is an Independent Variable

PMS49 Fatigue is an Independent Variable Predicting Physical Function and Das-28 Remission for Patients with Rheumatoid Arthritis Treated with Intravenously Administered Golimumab: Results from a Phase 3, Placebo Controlled Clinical Trial

✍ R. Westhovens; M.E. Weinblatt; C. Han; T. Gathany; L. Kim; M. Mack; J. Lu; D. Ba 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB